Target intelligence / Profile preview

Splicing factor 3A subunit 2 (SF3A2)

Target
SF3A2
Molecular classification
Other (Spliceosome-associated protein, RNA-binding protein, not a receptor, enzyme, transporter, or transcription factor)
01

Overview

Splicing factor 3A subunit 2 (SF3A2) is a core protein component of the SF3a complex, essential for spliceosome assembly and pre-mRNA splicing, which is required for removing introns from pre-mRNAs during gene expression. SF3A2 forms part of a heterotrimer with two other subunits and is involved in the conversion of the 15S U2 snRNP into the active 17S particle necessary for splicing. The SF3A2 protein contains a zinc finger domain that mediates RNA binding and interacts with subunit 1 via its amino-terminus. Beyond its canonical role in splicing, SF3A2 is implicated in mitotic chromosome segregation due to its ability to bind microtubules and localize to spindle microtubules. Genetic associations link SF3A2 to susceptibility loci in myocardial infarction, indicating a possible role in cardiovascular disease pathogenesis through alternative functions outside RNA processing. SF3A2 is not currently recognized as a direct therapeutic target, and no drugs are known to act on this protein.

Other names
PRP11PRPF11SAP62SAP 62SF3a66spliceosome-associated protein 62Splicing factor 3a, subunit 2, 66kDa
02

Biological functions

Pre-mRNA splicingSpliceosome assemblyRNA bindingMicrotubule binding (mitosis)
03

Disease associations

Cancer (role in cell proliferation and viability)Cardiovascular disease (association with myocardial infarction susceptibility)Myelodysplastic syndrome

Beyond the preview

Go deeper on Splicing factor 3A subunit 2 (SF3A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Splicing factor 3A subunit 2 (SF3A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call